In:
Cancer, Wiley, Vol. 122, No. 17 ( 2016-09), p. 2671-2679
Abstract:
In this single‐institution review of patients undergoing preoperative therapy before pancreatoduodenectomy for pancreatic ductal adenocarcinoma, the administration of hypofractionated chemoradiation is associated with margin‐negative resection rates, treatment effect, locoregional recurrence, and overall survival similar to those associated with standard fractionated chemoradiation. The use of either preoperative chemoradiation regimen is associated with improved locoregional control (but not overall survival) in comparison with systemic chemotherapy alone.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v122.17
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1
Permalink